senateStanding
Finance Committee
- Referred To
← Back to federal legislation
S. 665In committee
Fatal Overdose Reduction Act of 2025
Introduced: Feb 20, 2025
Latest action date: Feb 20, 2025
Your view
Current stage
In committee
The most advanced recorded stage is committee consideration.
Introduced
Feb 20, 2025
Latest action
Feb 20, 2025
Recorded roll calls
0
Civixly topics
What this legislation is about
Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.
HealthElections & GovernmentTransportationLabor & EmploymentBusiness & EconomyFamily & Social Services
Official CRS policy area
Health
View 16 official legislative subjects
Congressional oversightData collection, sharing, protectionDrug trafficking and controlled substancesDrug, alcohol, tobacco useEmployee hiringGovernment information and archivesHealth care costs and insuranceHealth care coverage and accessHealth personnelHealth programs administration and fundingHealth promotion and preventive careMedicaidMental healthPrescription drugsPublic contracts and procurementState and local government operations
Bill Summary
Fatal Overdose Reduction Act of 2025
This bill establishes a five-year Medicaid demonstration program to support the provision of comprehensive and accessible services to treat opioid use and substance use disorders.
Specifically, the bill establishes a demonstration program through which states may receive a Federal Medical Assistance Percentage (i.e., federal matching rate) of at least 90% for services provided by organizations that serve as Health Engagement Hubs. States must certify that these organizations provide a certain level of services, including physical and behavioral health services that are easily and quickly accessible, peer support services, and targeted case management. Organizations must also meet specified minimum staffing requirements, have a community advisory board, and be equipped to provide certain social services (e.g., employment counseling).
The Centers for Medicare & Medicaid Services (CMS) may select up to 10 states to participate in the program. The bill provides funds for state planning grants and administration of the program.
The CMS must contract with an entity to evaluate the program, and the Government Accountability Office must report on this evaluation.
Committee activity
Committees and subcommittees that received, reviewed, marked up, or reported this legislation.
Official committee record ↗
Amendments
Proposed changes to this measure, with their latest official outcome or action from Congress.gov.
No amendments are listed for this measure.
Checked against Congress.gov Sep 13, 2026.
Action timeline
Newest action first. Action language comes from the official Congress.gov record.
View full action timeline2 actions
Read twice and referred to the Committee on Finance.
IntroReferralSenateIntroduced in Senate
IntroReferralLibrary of Congress
Roll-call votes
Recorded House and Senate votes connected to this bill. Your representatives appear first when available.
No connected roll-call votes are currently available for this bill.
Discussion
0 comments
Sign in to join the discussion.Comments are publicly visible.
Loading comments...